Lidocaine Hydrochloride And Epinephrine Injection, Solution
Product Images NDC 0409-3178

25 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Epinephrine (NDC 0409-3178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Lidocaine 01)

FDA Label Image

Structural Formula Lidocaine Hydrochloride Usp (Lidocaine 02)

Structural Formula Lidocaine Hydrochloride Usp (Lidocaine 02)
Chemical structure diagram of Lidocaine Hydrochloride showing its molecular formula including aromatic ring, methyl groups, amide linkage, hydrochloride, and hydrate components as part of the active ingredient.*
FDA Label Image

Structrual Formula Epinephrine, Usp (Lidocaine 03)

Structrual Formula Epinephrine, Usp (Lidocaine 03)
Chemical structure diagram of epinephrine, showing the phenol ring with hydroxyl groups and side chain including a hydroxyl group and a methylated amine.*
FDA Label Image

Hospira Logo (Lidocaine 04)

FDA Label Image

Principal Display Panel (5 mL Ampule Label)

Principal Display Panel (5 mL Ampule Label)
Label for Lidocaine Hydrochloride 1.5% and Epinephrine 1:200,000 injection, USP, Epidural Test Dose, 5 mL vial. The label indicates it is distributed by Hospira, Inc., Lake Forest, Illinois, USA, with a barcode and placeholders for lot and expiration dates. It is marked as prescription only.*
FDA Label Image

Principal Display Panel (5 mL Ampule Tray Label)

Principal Display Panel (5 mL Ampule Tray Label)
Label for Lidocaine HCl 1.5% and Epinephrine 1:200,000 Injection, USP, 5 mL single-dose ampuls, distributed by Hospira, Inc. The label specifies it is an epidural test dose for use during epidural anesthesia, containing 15 mg/mL lidocaine HCl and 5 mcg/mL epinephrine, with instructions on storage, usage warnings, and a barcode.*
FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
Label for Lidocaine Hydrochloride 1.5% and Epinephrine 1:200,000 injection solution as an epidural test dose. The 5 mL vial is labeled for Rx use only and distributed by Hospira, Inc., Lake Forest, Illinois. The label includes the NDC 0409-1209-70 and placeholders for lot number and expiration date.*
FDA Label Image

Principal Display Panel (50 mL Vial Tray)

Principal Display Panel (50 mL Vial Tray)
Label of Lidocaine HCl 0.5% and Epinephrine 1:200,000 Injection, USP solution, 5 mg/mL lidocaine and 5 mcg/mL epinephrine strength, in a 50 mL multiple-dose vial. The label includes warnings for nerve block use only and not for epidural or caudal use. It is distributed by Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Label of Lidocaine HCl 0.5% (5 mg/mL) and Epinephrine 1:200,000 Injection, USP in a 50 mL multiple-dose fliptop vial. The label states that the product is for infiltration and nerve block, not for epidural or caudal use. It is manufactured and distributed by Hospira, Inc. This human prescription drug label includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
Label for Lidocaine HCl 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP, 20 mL multiple-dose vial. The label includes warnings for use in infiltration and nerve block, not for epidural or caudal use, and contains manufacturer Hospira, Inc. information with its address in Lake Forest, IL.*
FDA Label Image

Principal Display Panel (30 mL Vial Label)

Principal Display Panel (30 mL Vial Label)
Packaging label for Lidocaine Hydrochloride 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP, a 20 mL multiple-dose fliptop vial. The label includes storage instructions, supplier information for Hospira, Inc., and warnings against epidural or caudal use. The label also notes that it is for infiltration and nerve block, with lot number, barcode, and NDC information visible.*
FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
Label for Lidocaine Hydrochloride 1% (10 mg/mL) and Epinephrine 1:100,000 Injection, USP in a 30 mL multiple-dose vial. The label highlights the product's use for infiltration and nerve block and includes dosage strength in red font. It is distributed by Hospira, Inc., with warnings to protect from light and not to autoclave.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Packaging label for Lidocaine HCl 1% 300 mg/30 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP, a solution for injection by Hospira, Inc. This 30 mL multiple-dose fliptop vial container label features the proprietary and generic names, strengths, usage instructions indicating it is for infiltration and nerve block, and warnings against epidural or caudal use. The label also includes storage instructions, lot and expiry placeholders, and a barcode.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
The label for Lidocaine Hydrochloride 1% (10 mg/mL) and Epinephrine 1:100,000 injection, USP, presents a 50 mL multiple-dose vial. It is indicated for infiltration and nerve block use only and is not for epidural or caudal use. Distributed by Hospira, Inc., Lake Forest, IL. The label includes detailed preservative and pH information, plus storage instructions.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Packaging label for Lidocaine Hydrochloride 1% 500 mg/50 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP. The label indicates a 50 mL multiple-dose fliptop vial, for infiltration and nerve block use. It is labeled as Rx only with warnings about protection from light and not for epidural or caudal use. The labeler is Hospira, Inc.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
Label for Lidocaine HCl 1.5% and Epinephrine 1:200,000 Injection, USP, 30 mL single-dose vial. Contains 450 mg lidocaine HCl and epinephrine 1:200,000 per 30 mL (15 mg/mL). Intended for infiltration and nerve block including epidural and caudal use. Distributed by Hospira, Inc., Lake Forest, IL. Includes storage and dosage information, NDC 0409-3181-11.*
FDA Label Image

Lidocaine 17

Lidocaine 17
Packaging label for Lidocaine Hydrochloride 1.5% (450 mg/30 mL, 15 mg/mL) and Epinephrine 1:200,000 Injection, USP. The label indicates a 30 mL single-dose unit containing 5 fliptops vials. It includes storage instructions, usage warnings, and distributor information for Hospira, Inc. The label also contains barcode and NDC numbers 0409-3181-01 and 0409-3181-11.*
FDA Label Image

Lidocaine 18

Lidocaine 18
Label for Lidocaine Hydrochloride 2% Injection, USP with Epinephrine 1:100,000, 20 mL multiple-dose vial. The label states the strength as 400 mg per 20 mL (20 mg/mL) for lidocaine and includes directions for infiltration and nerve block. The product is distributed by Hospira Inc., Lake Forest, IL, USA, and contains additional information on ingredients and storage conditions.*
FDA Label Image

Lidocaine 19

Lidocaine 19
Label for Lidocaine HCl 2% 400 mg/20 mL (20 mg/mL) and Epinephrine 1:100,000 Injection, USP, multiple-dose fliptop vial. The label indicates the product is for infiltration and nerve block, not for epidural or caudal use. The labeler is Hospira, Inc., with storage instructions to protect from light and retain in carton until contents are used.*
FDA Label Image

Lidocaine 20

Lidocaine 20
Label for Lidocaine HCl 2% and Epinephrine 1:100,000 Injection, USP, 30 mL multiple-dose vial. Contains 600 mg Lidocaine HCl (20 mg/mL) and epinephrine 10 mcg per mL. Indicated for infiltration and nerve block, not for epidural or caudal use. Distributed by Hospira Inc., Lake Forest, IL.*
FDA Label Image

Lidocaine 21

Lidocaine 21
Carton label for Lidocaine HCl 2% 600 mg/30 mL (20 mg/mL) and Epinephrine 1:100,000 Injection, USP, a 30 mL multiple-dose fliptop vial. The label emphasizes that it is for infiltration and nerve block use only and is not for epidural or caudal use. The product is distributed by Hospira, Inc. The label includes storage instructions and warnings to protect from light and not autoclave.*
FDA Label Image

Lidocaine 22

Lidocaine 22
Label for Lidocaine Hydrochloride 2% (20 mg/mL) and Epinephrine 1:100,000 Injection, USP, multiple-dose 50 mL vial. The label states use is for infiltration and nerve block, not for epidural or caudal use. The label includes dosage details, NDC 0409-3182-31, manufacturer Hospira Inc., and storage instructions to protect from light.*
FDA Label Image

Lidocaine 23

Lidocaine 23
Label for Lidocaine HCl 2% 1000 mg/50 mL (20 mg/mL) and Epinephrine 1:100,000 Injection, USP in a 50 mL multiple-dose fliptop vial. The label states the product is Rx only and intended for infiltration and nerve block use, not for epidural or caudal use. Manufactured by Hospira, Inc.*
FDA Label Image

Lidocaine 24

Lidocaine 24
The packaging label for Lidocaine Hydrochloride 2% and Epinephrine Injection, USP highlights the strength as 400 mg/20 mL (20 mg/mL) lidocaine hydrochloride and epinephrine 1:200,000. It is a single-dose 20 mL injection solution, distributed by Hospira, Inc., Lake Forest, IL. The label indicates use for infiltration and nerve block, including epidural and caudal procedures. Additional details include NDC 0409-3183-11, storage instructions, lot number, and expiration date fields.*
FDA Label Image

Lidocaine 25

Lidocaine 25
Packaging label for Lidocaine HCl 2% (20 mg/mL) and Epinephrine 1:200,000 Injection, USP in a 20 mL single-dose vial. The product is distributed by Hospira, Inc. The label indicates protection from light, instructions for use, and storage conditions. The carton contains 5 fliptop vials and is intended for infiltration and nerve block, including epidural and caudal routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.